Pzena Investment Management LLC Makes New $45.31 Million Investment in Varex Imaging $VREX

Pzena Investment Management LLC bought a new position in Varex Imaging (NASDAQ:VREX) in the 2nd quarter, Holdings Channel.com reports. The firm bought 4,344,381 shares of the company’s stock, valued at approximately $45,312,000. Pzena Investment Management LLC owned approximately 0.10% of Varex Imaging at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of VREX. BlackRock Inc. purchased a new stake in shares of Varex Imaging during the 2nd quarter valued at about $40,624,000. Vanguard Group Inc. lifted its position in Varex Imaging by 4.4% during the 3rd quarter. Vanguard Group Inc. now owns 2,989,847 shares of the company’s stock worth $37,074,000 after acquiring an additional 126,396 shares in the last quarter. Cooke & Bieler LP boosted its holdings in Varex Imaging by 2.2% in the 4th quarter. Cooke & Bieler LP now owns 1,632,525 shares of the company’s stock worth $19,019,000 after acquiring an additional 35,042 shares during the period. Rice Hall James & Associates LLC purchased a new position in Varex Imaging in the 2nd quarter worth approximately $15,080,000. Finally, LSV Asset Management grew its position in Varex Imaging by 210.7% in the fourth quarter. LSV Asset Management now owns 1,244,329 shares of the company’s stock valued at $14,496,000 after acquiring an additional 843,805 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. B. Riley Financial lowered shares of Varex Imaging from a “buy” rating to a “hold” rating in a research note on Monday, August 10th. Weiss Ratings raised shares of Varex Imaging from a “sell (d-)” rating to a “sell (d+)” rating in a report on Tuesday, August 11th. Sidoti reaffirmed a “neutral” rating and set a $19.00 price target on shares of Varex Imaging in a research note on Monday, August 10th. Wall Street Zen raised shares of Varex Imaging from a “hold” rating to a “buy” rating in a research note on Saturday, July 4th. Finally, CJS Securities lowered shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a report on Monday. Six research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Reduce” and an average target price of $16.88.

Varex Imaging Trading Down 0.2%

Shares of NASDAQ VREX opened at $18.46 on Tuesday. The stock’s 50 day moving average price is $11.77 and its two-hundred day moving average price is $11.70. Varex Imaging has a 52-week low of $9.09 and a 52-week high of $18.63. The stock has a market capitalization of $777.17 million, a P/E ratio of 35.50 and a beta of 0.89. The company has a quick ratio of 1.53, a current ratio of 3.38 and a debt-to-equity ratio of 0.64.

Varex Imaging (NASDAQ:VREX) last released its earnings results on Monday, August 10th. The company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.21 by $0.10. The company had revenue of $210.50 million for the quarter, compared to the consensus estimate of $215.50 million. Varex Imaging had a return on equity of 9.19% and a net margin of 2.55%. On average, analysts anticipate that Varex Imaging will post 0.93 earnings per share for the current fiscal year.

About Varex Imaging

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.